{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:07:56Z","timestamp":1792181276051,"version":"4.4.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T00:00:00Z","timestamp":1616544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T00:00:00Z","timestamp":1616544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s00405-021-06757-x","type":"journal-article","created":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T19:03:17Z","timestamp":1616612597000},"page":"327-333","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinicopathological and immunohistochemical behavior of ductal carcinoma of the salivary and lacrimal gland in a Mexican Mestizo population"],"prefix":"10.1007","volume":"279","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1862-4036","authenticated-orcid":false,"given":"Kuauhyama","family":"Luna-Ortiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Dominguez-Malagon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo E.","family":"Corredor-Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Reynoso-Noveron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"Herrera-Ponzanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelik","family":"Luna-Peteuil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis C.","family":"Zacarias-Ramon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,24]]},"reference":[{"key":"6757_CR1","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1177\/107327481602300307","volume":"23","author":"MJ Mifsud","year":"2016","unstructured":"Mifsud MJ, Burton JN, Trotti AM, Padhya TA (2016) Multidisciplinary management of salivary gland cancer. Cancer Control 23:242\u2013248","journal-title":"Cancer Control"},{"key":"6757_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12105-017-0795-0","volume":"11","author":"RR Seethala","year":"2017","unstructured":"Seethala RR, Stenman G (2017) Update from 4th edition the of the World Health Organization Classification of the Head and Neck Tumour Tumors of the Salivary Gland. Head Neck Pathol 11:55\u201367","journal-title":"Head Neck Pathol"},{"key":"6757_CR3","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1002\/hed.24829","volume":"39","author":"M Mifsud","year":"2017","unstructured":"Mifsud M, Eskander A, Irish J, Gullane P, Gilbert R, Brown D, de Almeida JR, Urbach DR, Goldstein DP (2017) Evolving trends in head and neck cancer epidemiology: Ontario, Canada 1993\u20132010. Head Neck 39:1770\u20131778","journal-title":"Head Neck"},{"key":"6757_CR4","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1097\/PAS.0000000000000413","volume":"39","author":"L Williams","year":"2015","unstructured":"Williams L, Thompson LD, Seethala RR, Weinreb I, Assaad AM, Tuluc M, UdDin N, Purgina B, Lai C, Griffith CC, Chiosea SI (2015) Salivary duct carcinoma: the predominance of apocrine morphology, prevalence of histologic variants, and androgen receptor expression. Am J Surg Pathol 39:705\u2013713","journal-title":"Am J Surg Pathol"},{"key":"6757_CR5","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1002\/1097-0142(19900515)65:10<2307::AID-CNCR2820651024>3.0.CO;2-1","volume":"65","author":"MS Brandwein","year":"1990","unstructured":"Brandwein MS, Jagirdar J, Patil J, Biller H, Kaneko M (1990) Salivary duct carcinoma (cribriform salivary carcinoma of excretory ducts) A clinicopathologic and immunohistochemical study of 12 cases. Cancer 65:2307\u20132314","journal-title":"Cancer"},{"issue":"103","key":"6757_CR6","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1002\/cncr.21116","volume":"15","author":"M Jaehne","year":"2005","unstructured":"Jaehne M, Roeser K, Jaekel T, Schepers JD, Albert N, L\u00f6ning T (2005) Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases. Cancer 15(103):2526\u20132533","journal-title":"Cancer"},{"issue":"5","key":"6757_CR7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1001\/jamaoto.2015.3930","volume":"142","author":"MR Gilbert","year":"2016","unstructured":"Gilbert MR, Sharma A, Schmitt NC, Johnson JT, Ferris RL, Duvvuri U, Kim S (2016) A 20-year review of cases of salivary duct carcinoma. JAMA Otolaryngol Head Neck Surg 142(5):489\u2013495","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"6757_CR8","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1002\/cncr.21116","volume":"103","author":"M Jaehne","year":"2005","unstructured":"Jaehne M, Roeser K, Jaekel T, Schepers JD, Albert N, Loning T (2005) Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases. Cancer 103:2526\u20132533","journal-title":"Cancer"},{"key":"6757_CR9","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1007\/s12105-013-0456-x","volume":"7","author":"RHW Simpson","year":"2013","unstructured":"Simpson RHW (2013) Salivary duct carcinoma: new developments-morphological variants including pure in situ high grade lesions; proposed molecular classification. Head Neck Pathol 7:S48\u2013S58","journal-title":"Head Neck Pathol"},{"key":"6757_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10147-014-0674-6","volume":"20","author":"T Masubuchi","year":"2015","unstructured":"Masubuchi T, Tada Y, Maray S, Osamura Y, Kamata SE, Miura K, Fushimi C, Takahashi H, Kawakita D, Kishimoto S, Nagao T (2015) Clinicopathological significance of androgen Receptor, HER2, Ki-67 and EGFR expression in salivary duct carcinoma. Int J Clin Oncol 20:35\u201344","journal-title":"Int J Clin Oncol"},{"key":"6757_CR11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3857\/roj.2014.32.3.125","volume":"32","author":"TH Kim","year":"2014","unstructured":"Kim TH, Kim MS, Choi SH et al (2014) Postoperative radiotherapy in salivary ductal carcinoma: a single institution experience. Radiat Oncol J 32:125\u2013131","journal-title":"Radiat Oncol J"},{"key":"6757_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1590\/S0004-27492012000100014","volume":"75","author":"RW Ferreira-Damasceno","year":"2012","unstructured":"Ferreira-Damasceno RW, Holbach LM (2012) Primary ductal adenocarcinoma of the lacrimal gland: case report. Arq Bras Oftalmol 75:64\u201366","journal-title":"Arq Bras Oftalmol"},{"key":"6757_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s12105-013-0493-5","volume":"8","author":"RT Butler","year":"2014","unstructured":"Butler RT, Soector ME, Thomas D, McDaniel AS, McHugh JB (2014) An immunohistochemical panel for reliable differentiation of salivary duct carcinoma and mucoepidermoid carcinoma. Head Neck Pathol 8:133\u2013140","journal-title":"Head Neck Pathol"},{"key":"6757_CR14","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1093\/annonc\/mdt338","volume":"24","author":"J Cros","year":"2013","unstructured":"Cros J, Sbidian E, Hans S, Roussel H, Scotte F, Tartour E, Brasnu D, Laurent-Puig P, Bruneval P, Blons H, Badoual C (2013) Expression and mutational status of treatment-relevant target and key oncogenes in 123 malignant salivary gland tumours. Ann Oncol 24:2624\u20132629","journal-title":"Ann Oncol"},{"key":"6757_CR15","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1097\/PAS.0b013e3180caa099","volume":"31","author":"MD William","year":"2007","unstructured":"William MD, Roberts D, Blumenschein GR, Temam S, Kies MS, Rosenthal DI, Weber RS, El-Naggar AK (2007) Differential expression of hormonal and growth factor receptor in salivary duct carcinomas: Biologic significance and potential role in therapeutics stratification of patients. Am J Surg Pathol 31:1645\u20131652","journal-title":"Am J Surg Pathol"},{"key":"6757_CR16","doi-asserted-by":"publisher","first-page":"e476","DOI":"10.1200\/JCO.2010.32.8351","volume":"29","author":"HCJ Jaspers","year":"2011","unstructured":"Jaspers HCJ, Verbist BM, Schoffelen R, Mattijssen V, Slootweg PJ, va der Graaf WT, van Herpen CM (2011) Androgen receptor-positive salivary duct carcinoma: a disease entity with promising new treatment option. J Clin Oncol 29:e476\u2013e476","journal-title":"J Clin Oncol"},{"key":"6757_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1155\/2014\/162534","volume":"162534","author":"M Shahid Iqbal","year":"2014","unstructured":"Shahid Iqbal M, Saikh G, Chatterjee S, Cocks H, Kovaril J (2014) Maintenance therapy with trastuzumab in Her2 positive metastatic parotid ductal adenocarcinoma. Case Rep Oncol Med 162534:4. https:\/\/doi.org\/10.1155\/2014\/162534","journal-title":"Case Rep Oncol Med"},{"key":"6757_CR18","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/S1368-8375(03)00097-6","volume":"39","author":"R Haddad","year":"2003","unstructured":"Haddad R, Colevas AD, Krane JF et al (2003) Herceptin in patients with advanced or metastatic salivary gland carcinomas. A phase II study. Oral Oncol 39:724\u2013727","journal-title":"Oral Oncol"},{"key":"6757_CR19","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.1200\/JCO.2007.11.8612","volume":"25","author":"M Agulnik","year":"2007","unstructured":"Agulnik M, Cohen EWE, Cohen RB et al (2007) Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and\/or erbB2 expresssing adenoid cystic carcinoma and non-adenoid cystic carcinoma malignant tumors of the salivary glands. J Clin Oncol 25:3978\u20133984","journal-title":"J Clin Oncol"},{"key":"6757_CR20","first-page":"330","volume":"32","author":"Y Demir","year":"2013","unstructured":"Demir Y, Suruci E, Durak MG et al (2013) Contralateral parotideal lymph node metastasis detected by PET\/CT in female patient with locally advanced breast cancer. Rev Esp Med Nucl Imagen Mol 32:330\u2013331","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"6757_CR21","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1007\/s12105-017-0882-2","volume":"12","author":"JB Jalaly","year":"2018","unstructured":"Jalaly JB, Sanati S, Chernock RD, Dibe DG, El-Mofty S (2018) Salivary duct carcinoma and invasive ductal carcinoma of the breast: a comparative immunohistochemical study. Head Neck Pathol 12:488\u2013492","journal-title":"Head Neck Pathol"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-021-06757-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-021-06757-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-021-06757-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T10:05:33Z","timestamp":1641463533000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-021-06757-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,24]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["6757"],"URL":"https:\/\/doi.org\/10.1007\/s00405-021-06757-x","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,24]]},"assertion":[{"value":"28 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare that are relevant to the content of this article. All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript. The authors have no financial or proprietary interests in any material discussed in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was reviewed and approved by the Institutional Review Board and registered under the number Rev\/033\/20.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}